Skip to content
← Back to this collection

PUBLICATIONS · 25267746

Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2014 Nov 1
First author
Walterhouse DO

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2018 May 10;36(14):1459. doi: 10.1200/JCO.2018.78.2367.
    note
    Source null
    related pmid
    31329699
    relationship
    Erratum in

Authors and identifiers

  1. name
    Walterhouse DO
    type
    Author
  2. name
    Pappo AS
    type
    Author
  3. name
    Meza JL
    type
    Author
  4. name
    Breneman JC
    type
    Author
  5. name
    Hayes-Jordan AA
    type
    Author
  6. name
    Parham DM
    type
    Author
  7. name
    Cripe TP
    type
    Author
  8. name
    Anderson JR
    type
    Author
  9. name
    Meyer WH
    type
    Author
  10. name
    Hawkins DS
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Walterhouse DO
    type
    Author
  2. name
    Pappo AS
    type
    Author
  3. name
    Meza JL
    type
    Author
  4. name
    Breneman JC
    type
    Author
  5. name
    Hayes-Jordan AA
    type
    Author
  6. name
    Parham DM
    type
    Author
  7. name
    Cripe TP
    type
    Author
  8. name
    Anderson JR
    type
    Author
  9. name
    Meyer WH
    type
    Author
  10. name
    Hawkins DS
    type
    Author
bibliography ids
  1. nci-bib-1fba51a5811f4c75cd68e89b
book metadata
content sha256
275455d188e0622c1af43190021f98e7eab0c03e34f94c1f9b1850a58e83ea00
document type
citation
dois
  1. 10.1200/JCO.2014.55.6787
electronic publication date
display
2014 Sep 29
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:25267746
immutable id
pubmed:25267746@275455d188e0622c1af43190021f98e7eab0c03e34f94c1f9b1850a58e83ea00
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
31
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3547-52
volume
32
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2018 May 10;36(14):1459. doi: 10.1200/JCO.2018.78.2367.
    note
    Source null
    related pmid
    31329699
    relationship
    Erratum in
outcomes validated
false
pmid
25267746
provenance
batch id
69903be8ceab8801c81a
provider
NCBI PubMed ESummary
record sha256
e53ef95bbd9645a7d3a52e19f6b7ab9e0cc55a6f7ddc70ecf3d02f77b1c5d627
response sha256
1e367491c3c459a93f45b3db99ca1f9293ed2287c48bdf758bb088ffcd7c96eb
retrieved at
2026-09-09T23:47:05.208886+00:00
publication date
display
2014 Nov 1
precision
day
year
2014
publication types
  1. Clinical Trial
  2. Journal Article
  3. Multicenter Study
  4. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25267746/
title
Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

Preserved source evidence · Not medical advice